Whanin makes a leap to be an advancing company
that leads a healthy society,
| Category | Code | Target Disease | Exploration | Research | Preclinical | Clinical Phase 1 |
Clinical Phase 2 |
Clinical Phase 3 |
Drug Approval |
|---|---|---|---|---|---|---|---|---|---|
| New Drugs | WID-2101 | Parkinson’s |
|
||||||
| WID-2102 | Dementia |
|
|||||||
| WII-2001 | Cancer |
|
|||||||
| WII-2105 | Cancer |
|
|||||||
| WII-2201 | RA(Rheumatoid Arthritis) |
|
|||||||
| IMD | WIL-1901 | Dementia |
|
||||||
| Specialty Generics | WIT-2001 | Parkinson’s |
|
||||||
| WIG-2204 | Gastroesophageal Reflux Disease |
|
|||||||
| Generic | WIG-2002 | Depression |
|
||||||
| WIG-1810 | Epilepsy |
|
|||||||
| WIE-2201 | Migraine |
|
|||||||
| WIT-2201 | Dementia |
|
|||||||
| WIG-2202 | Epilepsy |
|
|||||||
| WIG-2203 | Dementia |
|
|||||||
| WIG-2206 | Dementia |
|
